Literature DB >> 7730889

The sickness impact profile: SIP68, a short generic version. First evaluation of the reliability and reproducibility.

A F de Bruin1, M Buys, L P de Witte, J P Diederiks.   

Abstract

In previous research a short version of the Sickness Impact Profile (SIP136) was developed, containing 68 items. This SIP68 is intended as a short generic alternative to the original SIP. High reliability of the SIP68 was reported when it was extracted from the SIP136. This paper is a report on the first reliability testing of the SIP68 administered as an independent instrument without the context of the SIP136. To establish the test-retest reliability and the internal consistency of the new instrument, 51 patients of an outpatient department of rheumatology completed the SIP68 twice, with an interval of 48 hours. To compare the performance of the independent SIP68 with the SIP68 extracted from the SIP136, the SIP136 also was completed two times by the same 51 respondents. Test-retest reliability for both administration types was assessed by means of the intraclass correlation coefficient and the Jaccard's similarity ratio. Internal consistency was assessed by means of Cronbach's alpha. The reliability appears to be high in both the independent SIP68 as well as the extracted SIP68. Moreover, the reliability of the independent SIP68 appears to be as high as for the SIP136. These findings were very encouraging, indicating that the SIP68 may very well serve as a generic alternative to the SIP136.

Entities:  

Mesh:

Year:  1994        PMID: 7730889     DOI: 10.1016/0895-4356(94)90189-9

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  16 in total

1.  Optimism and adaptation to multiple sclerosis: what does optimism mean?

Authors:  M Fournier; D de Ridder; J Bensing
Journal:  J Behav Med       Date:  1999-08

2.  The SIP68: an abbreviated sickness impact profile for disability outcomes research.

Authors:  Upasana Nanda; Patricia M McLendon; Elena M Andresen; Eric Armbrecht
Journal:  Qual Life Res       Date:  2003-08       Impact factor: 4.147

3.  Outcomes in cardiopulmonary physical therapy: sickness impact profile.

Authors:  Sheronda Bowers; Katie Cannizzaro; Jessica Gregus; Quanteria Scott; Jane Eason
Journal:  Cardiopulm Phys Ther J       Date:  2009-03

4.  Randomised controlled trial of effectiveness of Leicester hospital at home scheme compared with hospital care.

Authors:  A Wilson; H Parker; A Wynn; C Jagger; N Spiers; J Jones; G Parker
Journal:  BMJ       Date:  1999-12-11

Review 5.  Evaluation of instruments for measuring the burden of sport and active recreation injury.

Authors:  Nadine E Andrew; Belinda J Gabbe; Rory Wolfe; Peter A Cameron
Journal:  Sports Med       Date:  2010-02-01       Impact factor: 11.136

6.  Exercise--it's never too late: the strong-for-life program.

Authors:  A M Jette; M Lachman; M M Giorgetti; S F Assmann; B A Harris; C Levenson; M Wernick; D Krebs
Journal:  Am J Public Health       Date:  1999-01       Impact factor: 9.308

Review 7.  Quality of life instruments and definitions in individuals with spinal cord injury: a systematic review.

Authors:  M R Hill; V K Noonan; B M Sakakibara; W C Miller
Journal:  Spinal Cord       Date:  2009-12-22       Impact factor: 2.772

8.  Effect of family style mealtimes on quality of life, physical performance, and body weight of nursing home residents: cluster randomised controlled trial.

Authors:  Kristel A N D Nijs; Cees de Graaf; Frans J Kok; Wija A van Staveren
Journal:  BMJ       Date:  2006-05-05

9.  Exercise self-efficacy and control beliefs: effects on exercise behavior after an exercise intervention for older adults.

Authors:  Shevaun D Neupert; Margie E Lachman; Stacey B Whitbourne
Journal:  J Aging Phys Act       Date:  2009-01       Impact factor: 1.961

10.  The relationship between pain and functional disability in Black and White older adults.

Authors:  Ann L Horgas; Saunjoo L Yoon; Austin Lee Nichols; Michael Marsiske
Journal:  Res Nurs Health       Date:  2008-08       Impact factor: 2.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.